Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Wael Shehta

3PUBLICATIONS

4CO-AUTHORS

Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesBiomolecular modelling and design

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Oct 08, 2025

Synthesis, <i>in silico</i> and <i>in vitro</i> studies of aminopyrimidine hybrids as EGFR TK inhibitors and anti-proliferative agents.

Wael Shehta, Basant Farag, Shaker Youssif

|May 01, 2023

Synthesis and <i>in vitro</i> study of pyrimidine-phthalimide hybrids as VEGFR2 inhibitors with antiproliferative activity.

Wael Shehta, Fatimah Agili, Basant Farag

|Apr 03, 2023

Design, synthesis and antitumor activity of novel pyran-functionalized uracil derivatives: docking studies.

Wael Shehta, Fatimah Agili, Basant Farag

Pageof 1

Frequent Collaborators

3 joint publications

Shaker Youssif

3 joint publications

Samar El-Kalyoubi

2 joint publications

Sherin M Elfeky

1 joint publications

Basant Farag

Frequent Collaborators

3 joint publications

Shaker Youssif

3 joint publications

Samar El-Kalyoubi

2 joint publications

Sherin M Elfeky

1 joint publications

Basant Farag

Top Related Videos

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

<em>In Vitro</em> and <em>In Vivo</em> Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

<em>In Vitro</em> and <em>In Vivo</em> Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

Published on : Sep 29, 2023

Regioselective <em>O</em>-Glycosylation of Nucleosides <em>via</em> the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

Regioselective <em>O</em>-Glycosylation of Nucleosides <em>via</em> the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

Published on : Jul 26, 2018

See more related videos

Top Related Videos

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

<em>In Vitro</em> and <em>In Vivo</em> Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

<em>In Vitro</em> and <em>In Vivo</em> Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

Published on : Sep 29, 2023

Regioselective <em>O</em>-Glycosylation of Nucleosides <em>via</em> the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

Regioselective <em>O</em>-Glycosylation of Nucleosides <em>via</em> the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides

Published on : Jul 26, 2018

See more related videos